Caseware UK (AP4) 2023.0.135 2023.0.135 2023-05-312023-05-31172022-06-01falseNo description of principal activity17truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 05650428 2022-06-01 2023-05-31 05650428 2021-06-01 2022-05-31 05650428 2023-05-31 05650428 2022-05-31 05650428 c:CompanySecretary1 2022-06-01 2023-05-31 05650428 c:Director1 2022-06-01 2023-05-31 05650428 c:Director2 2022-06-01 2023-05-31 05650428 c:RegisteredOffice 2022-06-01 2023-05-31 05650428 d:Buildings d:ShortLeaseholdAssets 2022-06-01 2023-05-31 05650428 d:Buildings d:ShortLeaseholdAssets 2023-05-31 05650428 d:Buildings d:ShortLeaseholdAssets 2022-05-31 05650428 d:LandBuildings 2023-05-31 05650428 d:LandBuildings 2022-05-31 05650428 d:PlantMachinery 2022-06-01 2023-05-31 05650428 d:PlantMachinery 2023-05-31 05650428 d:PlantMachinery 2022-05-31 05650428 d:PlantMachinery d:OwnedOrFreeholdAssets 2022-06-01 2023-05-31 05650428 d:OwnedOrFreeholdAssets 2022-06-01 2023-05-31 05650428 d:CurrentFinancialInstruments 2023-05-31 05650428 d:CurrentFinancialInstruments 2022-05-31 05650428 d:Non-currentFinancialInstruments 2023-05-31 05650428 d:Non-currentFinancialInstruments 2022-05-31 05650428 d:CurrentFinancialInstruments d:WithinOneYear 2023-05-31 05650428 d:CurrentFinancialInstruments d:WithinOneYear 2022-05-31 05650428 d:Non-currentFinancialInstruments d:AfterOneYear 2023-05-31 05650428 d:Non-currentFinancialInstruments d:AfterOneYear 2022-05-31 05650428 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2023-05-31 05650428 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2022-05-31 05650428 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-05-31 05650428 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2022-05-31 05650428 d:ShareCapital 2023-05-31 05650428 d:ShareCapital 2022-05-31 05650428 d:OtherMiscellaneousReserve 2023-05-31 05650428 d:OtherMiscellaneousReserve 2022-05-31 05650428 d:RetainedEarningsAccumulatedLosses 2023-05-31 05650428 d:RetainedEarningsAccumulatedLosses 2022-05-31 05650428 d:AcceleratedTaxDepreciationDeferredTax 2023-05-31 05650428 d:AcceleratedTaxDepreciationDeferredTax 2022-05-31 05650428 d:RetirementBenefitObligationsDeferredTax 2023-05-31 05650428 d:RetirementBenefitObligationsDeferredTax 2022-05-31 05650428 c:OrdinaryShareClass1 2022-06-01 2023-05-31 05650428 c:OrdinaryShareClass1 2023-05-31 05650428 c:OrdinaryShareClass1 2022-05-31 05650428 c:FRS102 2022-06-01 2023-05-31 05650428 c:AuditExempt-NoAccountantsReport 2022-06-01 2023-05-31 05650428 c:FullAccounts 2022-06-01 2023-05-31 05650428 c:PrivateLimitedCompanyLtd 2022-06-01 2023-05-31 05650428 d:WithinOneYear 2023-05-31 05650428 d:WithinOneYear 2022-05-31 05650428 d:BetweenOneFiveYears 2023-05-31 05650428 d:BetweenOneFiveYears 2022-05-31 05650428 d:MoreThanFiveYears 2023-05-31 05650428 d:MoreThanFiveYears 2022-05-31 05650428 2 2022-06-01 2023-05-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 05650428









BLOODANDSAND LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MAY 2023

 
BLOODANDSAND LIMITED
 
 
COMPANY INFORMATION


Directors
P Mathew 
R A H Grantham 




Company secretary
R Grantham



Registered number
05650428



Registered office
39-45 Bermondsey Street

London

SE1 3XF




Accountants
Donald Reid Limited
Chartered Accountants

Prince Albert House

20 King Street

Maidenhead

Berkshire

SL6 1DT





 
BLOODANDSAND LIMITED
 

CONTENTS



Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 14


 
BLOODANDSAND LIMITED
REGISTERED NUMBER: 05650428

BALANCE SHEET
AS AT 31 MAY 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
200,837
235,155

  
200,837
235,155

Current assets
  

Stocks
 5 
24,571
29,446

Debtors: amounts falling due after more than one year
 6 
13,500
13,500

Debtors: amounts falling due within one year
 6 
58,161
77,694

Cash at bank and in hand
 7 
93,589
126,782

  
189,821
247,422

Creditors: amounts falling due within one year
 8 
(451,910)
(527,140)

Net current liabilities
  
 
 
(262,089)
 
 
(279,718)

Total assets less current liabilities
  
(61,252)
(44,563)

Creditors: amounts falling due after more than one year
 9 
(20,000)
(30,000)

Provisions for liabilities
  

Deferred tax
 11 
(32,048)
(57,996)

  
 
 
(32,048)
 
 
(57,996)

Net liabilities
  
(113,300)
(132,559)


Capital and reserves
  

Called up share capital 
 12 
15
15

Other reserves
  
37,272
37,272

Profit and loss account
  
(150,587)
(169,846)

  
(113,300)
(132,559)


Page 1

 
BLOODANDSAND LIMITED
REGISTERED NUMBER: 05650428
    
BALANCE SHEET (CONTINUED)
AS AT 31 MAY 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 18 January 2024.




P Mathew
Director

The notes on pages 3 to 14 form part of these financial statements.

Page 2

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

1.


General information

BloodandSand Limited is a private company limited by shares. The company was incorporated in the United Kingdom and is registered in England and Wales. The registration number is 05650428. The company's registered office is 39-45 Bermondsey Street, London, SE1 3XF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

At the year end the company has net liabilities of £113,300 (2022: £132,559). However, as the company continues to be supported by the directors it is considered appropiate to prepare the accounts on the going concern basis.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.4

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Page 3

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

2.Accounting policies (continued)

 
2.5

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Statement of income and retained earnings in the same period as the related expenditure.

 
2.6

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.8

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.9

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

2.Accounting policies (continued)

 
2.10

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Page 5

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

2.Accounting policies (continued)

 
2.11

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

The estimated useful lives range as follows:

Short-term leasehold property
-
15
years
Plant and machinery
-
5
years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.12

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. 
At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.13

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.14

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.15

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 6

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

2.Accounting policies (continued)

 
2.16

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance sheet.

 
2.17

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Page 7

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

2.Accounting policies (continued)


2.17
Financial instruments (continued)

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.


3.


Employees

The average monthly number of employees, including directors, during the year was 17 (2022 - 17).

Page 8

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

4.


Tangible fixed assets





Short-term leasehold property
Plant and machinery
Total

£
£
£



Cost or valuation


At 1 June 2022
439,597
73,870
513,467


Additions
-
1,302
1,302



At 31 May 2023

439,597
75,172
514,769



Depreciation


At 1 June 2022
222,577
55,735
278,312


Charge for the year on owned assets
28,139
7,481
35,620



At 31 May 2023

250,716
63,216
313,932



Net book value



At 31 May 2023
188,881
11,956
200,837



At 31 May 2022
217,020
18,135
235,155




The net book value of land and buildings may be further analysed as follows:


2023
2022
£
£

Short leasehold
188,881
217,020

188,881
217,020


Page 9

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

5.


Stocks

2023
2022
£
£

Stocks
24,571
29,446

24,571
29,446



6.


Debtors

2023
2022
£
£

Due after more than one year

Other debtors
13,500
13,500

13,500
13,500


2023
2022
£
£

Due within one year

Other debtors
15,327
19,506

Prepayments and accrued income
42,834
58,188

58,161
77,694



7.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
93,589
126,782

93,589
126,782


Page 10

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

8.


Creditors: Amounts falling due within one year

2023
2022
£
£

Bank loans
10,000
9,999

Other loans
69,579
88,175

Trade creditors
61,242
83,194

Corporation tax
6,295
19,280

Other taxation and social security
41,546
38,269

Other creditors
213,948
269,756

Accruals and deferred income
49,300
18,467

451,910
527,140



9.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Bank loans
20,000
30,000

20,000
30,000


Page 11

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

10.


Loans


Analysis of the maturity of loans is given below:


2023
2022
£
£

Amounts falling due within one year

Bank loans
10,000
9,999

Other loans
69,579
88,175


79,579
98,174

Amounts falling due 1-2 years

Bank loans
10,000
10,000


10,000
10,000

Amounts falling due 2-5 years

Bank loans
10,000
20,000


10,000
20,000


99,579
128,174


Page 12

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

11.


Deferred taxation




2023


£






At beginning of year
(57,996)


Charged to profit or loss
25,948



At end of year
(32,048)

The provision for deferred taxation is made up as follows:

2023
2022
£
£


Accelerated capital allowances
(32,221)
(58,267)

Other timing differences
173
271

(32,048)
(57,996)


12.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



58 (2022 - 58) Ordinary shares of £0.25 each
15
15



13.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company  in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £11,935 (2022: £10,070). Contributions totalling £1,247 (2022: £1,085) were payable to the fund at the balance sheet date and are included in creditors.

Page 13

 
BLOODANDSAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

14.


Commitments under operating leases

At 31 May 2023 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2023
2022
£
£


Not later than 1 year
121,000
121,000

Later than 1 year and not later than 5 years
357,333
433,333

Later than 5 years
33,750
78,750

512,083
633,083


15.


Related party transactions

At the year-end, included in other creditors, is an amount of £178,059 (2022: £232,059) owed to the directors by the company.
At the year-end, included in other loans due within one year, is an amount of £69,579 
(2022: £88,175) owed to shareholders by the company.

 
Page 14